NCT00000331撤回2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Observed withdrawal rating
研究概览
简要总结
The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependent volunteers.
详细描述
not available at this time
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals must be healthy, non-drug dependent volunteers, be at least 18 years of age, and have no prior history of drug or alcohol abuse or dependence. Subjects must have had some minimal experience with opioids (e.g. at least two prior exposures)
排除标准
- •Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.
研究组 & 干预措施
Test Drug
Experimental
Test drug to prevent heroine withdrawal
干预措施: Test Drug (Drug)
Placebo Pill
Placebo Comparator
Placebo drug
干预措施: Placebo Drug (Drug)
结局指标
主要结局
Observed withdrawal rating
Drug effect characteristics
Pupil diameter
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4Heroin DependenceOpioid-Related DisordersNCT00000329University of Colorado, Denver
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5Heroin DependenceOpioid-Related DisordersNCT00000330University of Colorado, Denver
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
不适用
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid UsersOpioid-Related DisordersNCT00158236National Institute on Drug Abuse (NIDA)7
已完成
2 期
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2Opioid-Related DisordersSubstance-Related DisordersNCT00000319Yale University
